Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesHydralazine-Induced ANCA-Positive Pauci-immune Glomerulonephritis: A Case Report and Literature Review
Renal Failure, 10/29/09
Dobre M et al. – This case represents a hydralazine–induced small vessel vasculitis rather than an idiopathic one. The possibility of hydralazine–induced vasculitis should be considered when patients treated with hydralazine develop a pulmonary–renal syndrome. Anti–histone antibodies may be present in the absence of full classification criteria of drug–induced lupus.
Related Articles
Renal Progenitor Cells Contribute to Hyperplastic Lesions of Podocytopathies and Crescentic Glomerulonephritis
Journal of the American Society of Nephrology, 11/03/09
Relevance Score: 87%
Acute post-streptococcal glomerulonephritis in children of French Polynesia: a 3-year retrospective study
Pediatric Nephrology, 11/04/09
Relevance Score: 85%
The Spectrum of Adult Postinfectious Glomerulonephritis in the New Millennium
Renal Failure, 10/26/09
Relevance Score: 85%
Th1 and Th17 Cells Induce Proliferative Glomerulonephritis
Journal of the American Society of Nephrology, 10/12/09
Relevance Score: 85%
Atorvastatin enhances humoral immune responses but does not alter renal injury in experimental crescentic glomerulonephritis
Nephrology, 10/05/09
Relevance Score: 85%
Today in Nephrology...keeping you current
Receive free subspecialty "5-minute updates" via email
Vasculitis
Journal of Allergy and Clinical Immunology, 12/04/09
Does endothelin B receptor deficiency ameliorate the induction of peritoneal fibrosis in experimental peritoneal dialysis
Nephrology Dialysis Transplantation, 12/04/09
External Validation of the Mayo Clinic Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear-Cell Renal Cell Carcinoma in a Single European Centre Applying Routine Pathology
European Urology, 12/04/09
Sponsor
Article Search
Sponsor
Sponsor